Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Asset Utilization Ratio: 2014-2017

Historic Asset Utilization Ratio for Soleno Therapeutics (SLNO) over the last 2 years, with Jun 2017 value amounting to 0.03.

  • Soleno Therapeutics' Asset Utilization Ratio fell 78.22% to 0.03 in Q2 2017 from the same period last year, while for Jun 2017 it was 0.03, marking a year-over-year decrease of 78.22%. This contributed to the annual value of 0.21 for FY2016, which is 187.94% up from last year.
  • Latest data reveals that Soleno Therapeutics reported Asset Utilization Ratio of 0.03 as of Q2 2017, which was down 38.70% from 0.04 recorded in Q1 2017.
  • Soleno Therapeutics' 5-year Asset Utilization Ratio high stood at 0.15 for Q4 2016, and its period low was -0.82 during Q4 2014.
  • Its 3-year average for Asset Utilization Ratio is -0.03, with a median of 0.06 in 2015.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first spiked by 160.51% in 2016, then slumped by 78.22% in 2017.
  • Over the past 4 years, Soleno Therapeutics' Asset Utilization Ratio (Quarterly) stood at -0.82 in 2014, then surged by 109.58% to 0.08 in 2015, then skyrocketed by 95.14% to 0.15 in 2016, then plummeted by 78.22% to 0.03 in 2017.
  • Its Asset Utilization Ratio stands at 0.03 for Q2 2017, versus 0.04 for Q1 2017 and 0.15 for Q4 2016.